搜尋結果
2024年4月23日 · Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines Read the Press Release May 2, 2024
4 天前 · Novavax stock ( NVAX) skyrocketed Friday, up 120% on the news that French drug and vaccine giant Sanofi ( SNY) is investing $1.2 billion in a deal for Novavax's COVID-19 vaccine as well as a minority stake in the struggling biotech company. The deal gave Novavax a much-needed cash boost, helping it reverse more than a year of declining value.
4 天前 · Shares in Novavax almost doubled after Sanofi struck a licensing deal worth up to $1.2bn to commercialise the struggling Covid-19 vaccine maker’s coronavirus jab and use the technology to ...
2024年4月30日 · View the latest press releases and media resources from the global healthcare and pharmaceutical company Sanofi
1 天前 · Sanofi on Monday announced it would invest over 1 billion euros ($1.1 billion) to create new medicines and vaccine production capacities at three of its French sites. S&P 500 edges down, investors ...
1 天前 · Novavax on Friday said it had struck a licensing deal worth at least $1.2 billion with Sanofi for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm at double its ...
4 天前 · Novavax Inc. shares surged after the company signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a combined Covid-19 and flu shot. Novavax will receive $500 million ...
